The US Food and Drug Administration (FDA) has expanded the indication for Abbott Laboratories spinal cord stimulation (SCS) devices to include treatment of chronic back pain.
The Food and Drug Administration has approved Abbott s Proclaim XR spinal cord stimulation system for the treatment of diabetic peripheral neuropathy, the company announced.